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Abstract
The tracheal epithelium prevents via its highly effective clearance mechanism the contamination of the lower airways by
pathogens. This mechanism is driven by ciliary bearing cells which are not only in contact with the gas phase; in addition
they are also influenced by inflammatory mediators. These mediators can alter the protective function of the epithelium.
Since the pro-inflammatoric cytokine tumor necrosis factor-a (TNF-a) plays a pivotal role within the inflammatory cascade,
we investigated its effect onto the tracheal epithelium measured by its ciliary beat frequency and the particle transport
velocity. In organ explant experiments the ciliary beat frequency and the particle transport velocity were measured under
the application of TNF-a using tracheae from male C57BL6J mice. We observed a dose dependent TNF-a induced increase of
both particle transport velocity and ciliary beat frequency. Knock out mice experiments made evident that the increase was
depended on the expression of tumor necrosis factor receptor 1 (TNF-R1). The increases in ciliary beat frequency as well as
the accelerated particle transport velocity were either inhibited by the unspecific serotonin antagonist methysergide or by
cyproheptadine a specific 5-HT2 receptor antagonist. Thus, acetylcholine antagonists or nitric oxide synthase (NOS)
inhibitors failed to inhibit the TNF-a induced activation. In conclusion, TNF-a may play a pivotal role in the protection of
lower airways by inducing ciliary activity and increase in particle transport velocity via TNF-R1 and 5-HT2 receptor.
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Introduction
The mucociliary clearance is an important defence mechanism
of the lower respiratory tract. This innate protector clears the
airway surface area from debris, infectious particles and pathogens
and is propelled by directed function of ciliary bearing cells
integrated in the airway epithelium. In addition to the mechanical
defence mechanism, a specific composition of mucus with a
balanced mixture of salt and water is an important regulation
factor for successful airway clearance. A defect of the cystic fibrosis
transmembrane conductance regulator (CFTR) gene causes a
dysfunction of the CFTR-protein. This protein defect, which
regulates the salt water balance, leads to dehydration of the
epithelia lining airway surface and results in an ineffective
clearance, formation of local inflammation and an increase of
chronic airway infections [1] [2]. These mechanisms show the
relevance of the epithelial cilia function and the clearing system in
connection with the innate immune system.
It is generally accepted that the protective beating function of
ciliary bearing cells is modulated by different stimuli. In addition
to cyclic adenosine monophosphate (cAMP) and intracellular
calcium concentration, cyclic guanosine monophosphate (cGMP)
seem to be important messengers to activate phosporylation and
mediate an increase in cilliary beat frequency [3]. Cholinergic
modulators, vasoactive peptides or nitric oxide (NO) all seem to
induce the synthesis of cGMP via activation of soluble guanylate
cyclase [4].
Among epithelial cells it has been assumed that other cell types
e.g. activated mast cells and platelets affect the mucociliary
transport via the endogenous mediator serotonin that can act as an
activator of ciliary beat function [5] [6]. It seems obvious that
ciliary function is constantly controlled by physiological neurome-
diators like acetylcholine or noradrenalin released from autonomic
nerve fibres or paracrine from other cell types [7] [8].
Beside this constant regulation of cilia bearing cells, further
modulators can alter ciliary function depending on physiological
or patho-physiological requirements. Among patho-physiological
processes inflammation leads to activation of the immune system
and early in this mechanism cytokines are generated and released,
which then can cause imbalances of organ functions. These
cytokines released during inflammation or infection may also
influence mucociliary clearance capacity [9].
Within in the family of pro-inflammatory cytokines, TNF-a
plays a key role in activation of immune cells integrated in the
cascade of host response to infections. However, TNF-a has not
only an impact on genuine immune cells, it also initiates functions
of cells associated to the immune system that provide specific
functions in the pro-inflammatory response. Beside cells of the
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innate and adaptive immune system, many other non-immune
cells are also capable of producing TNF-a like e.g. endothelial
cells, neuronal cell and cardiac myocytes. The effects of TNF-a are
mediated mainly via TNF-R1 which is found on many cell types
and TNF-a receptor-2 (TNF-R2) that is exclusively expressed by
immune cells. Upon binding, TNF-a upregulates pro-inflamma-
tory gene expression via different signal transduction cascades
including NF-kb or MAP kinase [10].
Nevertheless, the entire effects of cytokines onto the clearing
system of lower airways are still poorly understood. The tracheal
epithelium may be attributed to the immune system first by its
passive barrier function to block microbial intrusion, and second
by its active clearing mechanism driven by ciliary cells. For this
reason, we analysed the short term effects of TNF-a onto the
functions of tracheal epithelial cells by recording ciliary beat
frequency (CBF) and epithelial particle transport velocity (PTV) in
murine tracheae.
Materials and Methods
Preparation of tracheal segments and imaging
In the present study we used male C57BL6J (Charles River)
mice aged between 12 and 15 weeks (25–35 g). In a further series
of experiments we employed C57BL6J TNF-R1 knock out mice
(Jackson Laboratory, B6.129-Tnfrsf1atm1Mak/J), which are estab-
lished animals for mice deficient in TNF-R1 with a C57BL6J
background strain [11] [12]. For all experiments care and use of
the animals were performed according to the German guidelines.
The protocol was approved by the Animal Welfare Office of the
Justus-Liebig-University Giessen (Permit Numbers: 428_AZ 306
and 443_M 932). The animals were sacrificed by inhalation of an
overdose isoflurane (Baxter, Unterschleibheim, Germany) in a
closed chamber. Immediately after confirmation of death, the
trachea was removed by opening the thorax via a parasternal
incision and median incision of the throat. In situ, the trachea was
carefully explanted by cutting cranial to the bifurcation and caudal
of the larynx. The trachea was then directly transferred into a
Delta T culture dish (Bioptechs, Butler, PA, USA) filled with 2 ml
of cooled (4–8uC) HEPES-buffer (pH 7.4). To enable proper
positioning of the trachea inside the dish, the bottom was
previously coated with Sylgard polymer (Dow Corning, Wiesba-
den, Germany). Organs were fixed using two fine minutiae (Fiebig
Lehrmittel, Berlin, Germany) in a position in which the cartilage
arches were facing the Sylgard while the musculus trachealis was
facing upwards. This allowed the fine preparation including the
removal of connective tissue and surrounding blood vessels by
employing Vannas-Tu¨bingen spring scissors (FST, Heidelberg,
Germany). Finally, the pars musculus membranacea trachealis was
cut in longitudinal direction allowing a direct visualisation of the
respiratory epithelium while the tissue remained submerged in the
buffer solution. The HEPES buffer was replaced by 2 ml of fresh
HEPES buffer pH 7.4, 30uC and the dish was transferred to the
stage holder of an upright transmission light microscope (BX50
WI, Olympus, Hamburg, Germany) within 30 min after eutha-
nasia. The microscope was equipped with a temperature control
unit maintaining a constant temperature at 30uC throughout each
experiment in the centre of the dish. The imaging was performed
using a Till Vision imaging software (Till Photonics, Gra¨feling,
Germany).
Measurement of particle transport velocity
The particle tracking experiments were performed as described
before [5]. For measurement of PTV, 4 ml Dynabeads (mean
diameter between 2.8 mm to 4.5 mm; Dynal Biotech GmbH,
Hamburg, Germany) were added prior to each measurement into
the bath solution. Following, the surface of the tracheal epithelium
was focused via a 20 x water immersion lens (Olympus) in bright
field mode. To identify the transported Dynabeads, an area
between two cartilages was selected as shown in figure 1A. This
allowed recordings avoiding significant contrasts of the image
brightness. At each time point short movie sequences with high
sampling rates were recorded and subsequently analysed using
Image Pro Plus analysis software. At the end of each individual
experiment a viability proof of the ciliated cells in the trachea
epithelium was performed by the application of ATP (100 mM)
leading to maximal ATP-induced CBF increase. In each
experiment tracks of approximately 200 to 400 particles were
evaluated at certain pre-defined time points (figure 1B). At these
time points 200 images were acquired during a period of 16.726 s.
a background subtraction was performed pixel-by-pixel and non-
moving objects were excluded (200 images/16.726 s = 1 image/
83.63 ms). Via this subtraction the formerly images of the darker
polysterene Dynabeads were converted into bright images.
Conversion into a binary image with a threshold that allowed to
distinguish between the bright bead images and the dark
background. Reduction of the 12 bit film to an 8 bit film on a
greyscale enabled to follow individual particles via the TiLLvis-
TRAC software (Till Photonics) and calculating an average PTV
(figure 1C).
Measurement of ciliary beat frequency
To measure the CBF the epithelial cell layer of tracheae was
focused using a 40 x objective (Zeiss, Jena, Germany) (figure 1D).
Short movie sequences (9.523 s) were recorded with an EHD
SMX-150 M CMOS camera (EHD Imaging, Damme, Germany).
For evaluation of CBF 10 cells from each individual trachea (n =
6) were chosen and light-dark-transmissions were analysed with
Fourier-transformation analysis using 1000 images per time point
(105 images/s). The analysis was achieved via fast Fourier
transformation by administration of Autosignal 1.7 (SeaSolve
Software Inc., San Jose, CA, USA).
Viability of the tissue was ensured by adding ATP at the end of
each experiment. If the response to ATP failed the experiment was
not included into further statistical analysis.
Drugs and buffer solutions
The following drugs were administered: ATP (100 mM),
methysergide (100 mM), WAY-100635 (1 mM), L-NAME
(100 mM), L-NMMA (100 mM), atropine (1 mM) all from Sigma
(Deisenhofen, Germany) cyproheptadine (5 mg/ml) (TOCRIS
Bioscience, Bristol, UK).
Application of drugs taken from a stock solution (see above) was
performed with a pipette into the organ bath solution; end
concentration was achieved by gently mixing the buffer with a
pipette. All preparation and experiments were carried out in
HEPES solution consisting of : 20 mM HEPES, 4,5 mM KCl,
2,5 mM CaCl2, 11 mM Glucose, 140 mM NaCl, 1 mM MgCl2,
pH was adjusted to 7.4 at 30uC or 4–8uC for tissue preparation
using NaOH (4 molar).
TNF-a (PeproTech, Rocky Hill, New Jersey) was taken out of a
stock solution (100 ng/ml, diluted in water) that was freshly
prepared for each experimental day.
RT-PCR
For PCR analysis mRNA was isolated from tracheae that had
either been stimulated with TNF-a during PTV/CBF experiments
or untreated organs as control. For further positive controls we
isolated peripheral blood mononuclear cells (PBMC).
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The tissue was processed using a bead mill homogenizer (Cryo
Mill NM301, Retsch, Haan, Germany). Afterwards the superna-
tant was transferred into a gDNA eliminator column and then
centrifuged with 8000 g for 30 s. Immediately followed by the
mixture with 600 ml ethanol 70% and then 700 ml of this mixture
was placed in a RNeasy Plus Mini Kit (Qiagen, Hilden, Germany)
column. Two further centrifuge steps followed each at 8000 g for
15 s and in between the solution was resuspended with 700 ml RW
1 buffer solution. Thereafter 500 ml RPE buffer was added and the
suspension centrifuged by 8000 g for 15 s, followed by a 2 min
centrifugation. Eventually the solution was transferred into a
1.5 ml vessel and diluted with 50 ml RNase free water followed by
a final centrifugation step at 8000 g for 15 s.
Transcription of RNA to cDNA was conducted using the
Quantitect RTranscription kit (Qiagen, Hilden, Germany) by
transferring 1 mg RNA into 2 ml gDNA Wipeout Buffer and
dilution with RNase free water up to a total volume of 14 ml
followed by incubation at 42uC for 2 min and further addition of
1 ml reverse transcriptase, 4 ml Quantiscript RT buffer and 1 ml
RT primer omitted in control experiments. The transcription was
then performed at 42uC for 20 min and stopped by heating up to
92uC for 3 min. The obtained cDNA was stored at –80uC until
further PCR experiments.
PCR experiments were performed using the Promega-PCR-kit,
the master mix consisted of 50 ml flexi buffer, 20 ml MgCl2, 5 ml
dTNPs, 5 ml upstream primer and 5 ml downstream primer
1.25 ml DNA polymerase and 158.75 ml nuclease free water.
The primers used were as follows: TNF-R1 s: ATCTGCTG-
CACCAAGTGCC, as: TGCATGGCAGTTACACACG; TNF-
R2 s: TACCAAGGGTGGCATCTCTC, as: TCCTGGGATT-
TCTCATCAGG. Additional 5 ml of template cDNA was added
to the reaction solution, controls were conducted by the
application of 5 ml nuclease-free water. The PCR was performed
in a Mastercycler gradient (Eppendorf, Hamburg, Germany) for
40 min. administering the following cycle protocol: 95uC for 2 min
followed by 95uC for 1 min then 56uC for 1 min afterwards 72u for
1 min and for 30 cycles, followed once by 72uC for 5 min and
eventually cooling to 4uC. PCR products were evaluated by gel
electrophoresis using 2% agarose gel, each trace was loaded with
25 ml of the PCR product and then started with 95 V for 20 min
(Peqlab Biotechnology GmbH, Erlangen, Germany). The evalu-
ation was achieved in a chemiluminescence imager (Fusion – SL
Figure 1. A, B: Microscopy for PTV measurements. Section of microscopic top view on the tracheal epithelium between 2 cartilages for PTV
measurement (20x lens). A: Arrows indicate the applied particles (Dynabeads) B: Recorded particle tracks for PTV calculation. C: Representative
experimental setup: The stimulation phase started 60 minutes after organ explantation. Measurements were performed over a period of 60 minutes
(stimulation period). Vitality of the ciliary cells was tested by ATP application (1025 M) over 10 minutes (vitality test) (Control group, n = 5, Mean 6
S.E.M). D: Microscopy for CBF measurements. Section of microscopic top view between 2 cartilages for CBF measurement (40x lens). Encircled area
shows cilia bearing epithelial cell.
doi:10.1371/journal.pone.0091705.g001
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3500 WL) employing the Fusion software (both Vilber Lourmat,
Eberhardzell, Germany).
Positive controls were performed by using RNA that was
harvested from mice PBMC by small canules out of the heart after
the animals had been sacrificed with isoflurane. The blood sample
was transferred into a small glass tube containing 3 ml Ficoll and
then centrifuged at 1500 g at 10uC for 30 min. Afterwards the cell
layer containing the PBMC was pipetted into a fresh glas tube that
was filled with phosphate buffered saline (PBS) to 10 ml and then
centrifuged at 10uC at 6000 g for 10 min. The supernatant was
discarded and the cell pellet was resuspended with 10 ml PBS and
further centrifuged as mentioned above, the last step repeated
twice. Transcription from RNA into cDNA was performed after
transfer of the pellet into an Eppendorf cup and the RT protocol
was used as described for tracheal transcription (see above).
RNA extraction
The excised tracheae were homogenized in TRIzol (Life
Technologies, Carlsbad, USA) using a bead mill and subsequent
RNA extraction was performed using a combination of guanidi-
nium thiocyanate-phenol-chloroform separation followed by
column-based RNeasy Plus Mini Kit (Qiagen, Hilden, Germany)
extraction according to the manufacturer’s instructions. Briefly,
each trachea was individually homogenized in 1 ml of TRIzol,
then 200 ml chloroform were added, mixed and after 3 minutes
incubation at room temperature centrifuged at 12.000 x g for 15
minutes at 4uC. The aqueous phase containing the RNA was
removed and directly used for the further extraction using the
binding column. RNA was eluted from the column with 30 ml
RNAse-free water and stored at -80uC until further analysis.
Quantitative PCR
RNA concentration was photometrically measured and 350 ng
of each preparation was reverse transcribed using the QuantiTect
Reverse Transcription Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions including a genomic DNA
removal step and a prolonged RT synthesis step to ensure proper
transcription of difficult RNA species. Subsequent Real time PCR
analysis was performed on a StepOnePlusTM PCR cycler (Applied
Biosystems, Weiterstadt, Germany). Following pre-designed Taq-
Man assays were used: mouse 18S (assay ID Mm03928990_g1)
and mouse TNFR1a (assay ID Mm00441883_g1). PCR reactions
were set up using the TaqMan Universal PCR Master Mix
(Applied Biosystems, Weiterstadt, Germany). All experiments were
run in triplicate. Results are interpreted by calculating the 2DCt
(DCt: Ct 18S – Ct TNFR1a) of each sample.
Immunohistochemistry
For immunohistochemistry mice were sacrificed by an overdose
of isoflurane, after confirmation of death the tracheae were
harvested as described in previous sections. The organs were
transferred into 4% paraformaldehyde (PFA) in phosphate buffer
solution pH 7.2 for immersion fixation and stored overnight at
room temperature (21uC). After rinsing in phosphate buffer the
tissue was cryoprotected using 18% sucrose and then snap frozen
in Tissue Tek. Cryosections 10 mm were cut and mounted on glass
slides, air dried and subsequently incubated for 1 h using 10%
normal horse serum containing 0.5% Tween 20, 0.1% BSA in
PBS, pH 7.4. After removal of the blocking solution the sections
were incubated with the primary antibody against TNF-R1 (1:400
rabbit polyclonal, abcam, Cambridge, UK) overnight at room
temperature. Afterwards the antibody solution was rinsed off using
phosphate buffer. Secondary antibody was applied for 1 h at room
temperature using donkey anti rabbit 1:2000 linked with Cy3
(Chemicon, Hampshire, UK). Afterwards the secondary antibody
was rinsed off in phosphate buffer and then the sections were
further fixed in 4% PFA in 0.1 M phosphate buffer for 10 min.
and rinsed again in phosphate buffer and finally coverslipped in
carbonate buffered glycerol (pH 8.6). The tracheal sections were
evaluated using an epifluorescence microscope using a 40x lens
(Axioplan 2 imaging; Zeiss, Jena, Germany) fitted with the
appropriate filter sets. Specificity of the primary antibody against
TNF-R1 (1:400) was tested by re-absorption with the TNF-R1
peptide (60 mg/100 ml, Thermoscientific, Schwerte, Germany) at
8uC for 24 hrs. After this incubation the sample was centrifuged
for 1 min at 1000 rpm and then the tracheal sections were
incubated at room temperature over night. All other incubation
steps were performed identical as described for immunohisto-
chemical staining.
Statistical analysis
Certain pre-defined time points of different experiments were
compared using Mann-Whithney test. Statistical significance was
assumed when p,0.05.
Results
TNF- a increases doses dependent cilia driven PTV
All experiments were conducted using the same experimental
design: A resting period for 30 minutes (not shown) was used to
achieve a steady-state condition before stimulation, which started
60 minutes after confirmed death. Measurements were performed
over a period of 60 minutes. Vitality was proofed at the end of
each experiment by application of ATP (1025 M) at minute 60 and
further data sampling over 10 minutes (figure 1C).
Tracheae were stimulated 60 minutes after isoflurane induced
death with TNF-a in different concentrations (100 ng/ml,
250 ng/ml, 360 ng/ml and 1000 ng/ml). PTV was arbitrarily
set as 100% for minute 0 to normalise for inter-individual
variability (figure 2A).
Application of 100 ng/ml (p = 0.59) or 250 ng/ml (p= 0.39)
TNF-a did not result in an increase of the PTV compared to
control. In contrast, higher concentrations with 360 ng/ml
(p,0.01) or 1000 ng/ml (p,0.01) TNF-a evoked a significant
increase in cilia driven particle transport compared 60 minutes
after TNF-a application with the control group (figure 2B).
TNF-a enhanced CBF increases PTV
Under control conditions CBF remained stable throughout the
entire experimental period. Application of TNF-a (360 ng/ml) led
to an increase of the CBF that became significant from minute 48
until minute 60 (p,0.01, figure 3A).
TNF-a-induced increase of CBF strongly correlates (r = 0.83,
p,0.001) with the parallel increase in PTV during the stimulation
period and the vitality phase (figure 3B). This suggests that in these
experiments an enhanced CBF is the underlying mechanism of
higher transport velocities.
Evidence for tracheal TNF-R1 mRNA expression
To further evaluate which receptors are involved in the TNF-a
induced mechanism we performed both RT-PCR and qPCR
experiments on freshly isolated tracheae and on organs that had
previously been stimulated with TNF-a during CBF or PTV
experiments. In control experiments using freshly harvested whole
tracheae we detected mRNA of the TNF-R1 but not of TNF-R2.
TNF-R2 mRNA was neither detected in control nor in TNF-a
treated tracheae (RT-PCR; n= 3; figure 4A). In TRIzol homo-
genated tracheae (again using whole tracheal walls) that had been
TNF-a Induces Early Ciliary Transport Velocity
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exposed to TNF-a (360 ng) over 60 min the gene expression of
TNF-R1 was detectable. In these tracheae the TNF-R1 mRNA
showed a trend to be increased using qPCR. However, this rise in
mRNA reached not statistical significance (p= 0.2, n = 4, figure
4B).
The TNF-R1 is exclusively located in tracheal epithelium
In order to investigate the location of cells expressing the TNF-
R1 peptide in the entire trachea, immunohistochemical stainings
of tracheae were performed. In fact, incubation with an antibody
against TNF-R1 led to a high enrichment of immunoreactivity in
small cells embedded in the epithelium (figure 4C). These TNF-R1
immunoreactive positive cells were exclusively located in the
tracheal epithelium and were either isolated or occurred in small
groups (2–4 cells), (figure 4C–D). The specificity of the antibodies
was proofed using both pre-absorption with TNF-R1 peptide and
omitting of the primary antibody (figure 4E, F).
TNF-a-induced changes are TNF-R-1-dependent
TNF-a 1000 ng/ml led to a significant CBF elevation in wild-
type (wt-J) mice. In contrast, the same concentration TNF-a could
not provoke an increase in CBF in TNF-R1 knock-out mice (–/–)
(figure 5A). The concentration dependent reaction of TNF-a of
360 ng/ml or 1000 ng/ml showed a significant difference between
minute 0 and minute 60 in wt-mice. When TNF-a was applied at
Figure 2. A: TNF-a induced increase in PTV. Exposure to TNF-a
(360 ng/ml) induced an increase in PTV with a delay of approximately
24 min, the increase in PTV was already significant after 30 min of
application (p,0.05). After a brief plateau in which the increased PTV
did not reach the threshold of statistical significance, it further rose, still
in the presence of TNF-a, from minute 51. It eventually reached its
maximum between 51 and 60 minutes after TNF-a application
(p,0.001, vitality test not shown, TNF-a: 360 ng/ml, n = 5, Mean 6
S.E.M.). B: Concentration dependency of TNF-a induced PTV. Cilia driven
PTV is shown during the application of TNF-a at minute 0. Application
of TNF-a 100 ng/ml (n = 9) or 250 ng/ml (n = 4) showed a trend to
enhance cilia driven PTV compared to control (n = 9; p = 0.4). The PTV
increased significantly until minute 60 during continuous stimulation
with 360 ng/ml TNF-a (n = 5, p,0.01, compared to control) or 1000 ng/
ml (n = 4, p,0.01, compared to control, Mean 6 S.E.M.) Kolmogorow-
Smirnow-test followed by Mann Whitney U-test.
doi:10.1371/journal.pone.0091705.g002
Figure 3. A: TNF-a increases CBF. Under control conditions no changes
in CBF were observed. Here only the application of TNF-a (360 ng/ml,
n = 5) at minute 0 is shown this responded by a rapid increase in CBF,
that became significant from minute 48 (p,0.05), reaching its
maximum at minute 57 (before ATP application, p,0.05) compared
to control (n = 5). (Mann Whitney U-test (Mean 6 S.E.M.). B: Correlation
of cilia driven particle transport with CBF. Increase of CBF (mean values;
n = 5) during the exposure to TNF-a (360 ng/ml) strongly correlates
(r = 0.83, p,0.001) with the parallel increase in PTV (mean values; n = 5)
during the chosen observation period (Spearman correlation test for
nonparametric correlation).
doi:10.1371/journal.pone.0091705.g003
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minute 0 neither 360 ng/ml nor 1000 ng/ml caused a significant
enhancement at minute 60 (figure 5B).
Methysergide and cyproheptadine block the TNF-a
induced increase in PTV
The PTV of the tracheae were compared 60 minutes after the
stimulation with TNF-a (360 ng/ml) and a pre-incubations with
either a NOS inhibitor (L-NMMA) or a muscarinic receptor
blocker (atropine) were performed. Neither atropine (1 mM), nor
L-NMMA (100 mM) or L-NAME (100 mM data not shown) could
prevent a TNF-a induced increase in the PTV of tracheal
epithelium (figure 6A). Administration of atropine (1 mM, n= 4,
p = 0.31) or L-NMMA (100 mM, n= 4, p= 0.19) omitting TNF-a
had no effect on PVT when compared to control (data not shown).
In addition a serotonin related effect was analysed using different
pharmacological agents. The unspecific inhibitor methysergide
(100 mM) completely reduced the TNF-a evoked increase in PTV
(p,0.05, n = 4). Furthermore we administered specific serotonin
receptor antagonists. WAY-100635 (1 mM, specific inhibitor of the
serotonin receptor 5-HT1A) did not alter the response to TNF-a
(p = 0.22, n= 5), wereas cyproheptadine (14 mM, specific inhibitor
of 5-HT2) completely inhibited the TNF-a evoked increase in
PTV (p,0.01, n = 5, figure 6B). Compared to control experiments
neither methysergide (p = 0.85), cyproheptadine (p= 0.4) nor
WAY-100635 (p = 0.4) had a significant influence on PTV when
applied without TNF-a.
Discussion
In the present study we provided evidence for an early TNF-a
triggered increase in PTV and CBF. The mucociliary clearing
system is an important innate lung protective mechanism to
disburden the airway surface area from debris and pathogen
particles. In addition to the active mechanical clearing, a specific
composition of mucus covers as a thin liquid layer the entire
epithelium of lower airways and lungs to reduce the surface
tension. Additional the surfactant contains ATP, that has been
released by pulmonary epithelial cells, which stimulates purinergic
receptors P2Y on apical membranes of ciliary bearing epithelial
cells [13] [2] [14] [15]. In these epithelial cells the soluble adenylyl
cyclase is activated in close vicinity to the cilia, it synthesizes cAMP
subsequently enhancing CBF [16]. This oral directed ciliary
beating as well as the fine regulated composition of the airway
liquid layer together play an important well coordinated role in the
clearing mechanism of lower airways.
Nevertheless, additional different physiological factors like the
neuromediators acetylcholine, adrenaline and serotonin are
known as constant regulators to maintain the permanent ciliary
beating. Beside these classical modulators, under certain circum-
stances further physiological or patho-physiological conditions can
alter ciliary function [1] [17] [8]. During inflammation cytokines
play a key role in regulation of body function and among these
cytokines TNF-a contributes to multiple distinct pathways.
Beyond its pyrogenic effect as an inflammatory mediator [18],
TNF-a also functions as a major immunological trigger. It has a
Figure 4. Expression of TNF-R1 in tracheal epithelium. A: In RT-PCR experiments using whole tracheal preparations we found evidence for
mRNA of TNF-R1 but not TNF-R2 (n = 3, bp: 100 kD). B: In tracheae previously exposed to TNF-a over 60 min we observed a non-significant increase
in TNF-R1 mRNA when using qPCR (p = 0.2, n = 4). C: In addition immunoreaction against TNF-R1 was used to identify the anatomical location of the
TNF-R1. Immunoreaction against TNF-R1 stained only cells within the epithelial layer. These were either found as isolated cells or as clusters of 2–4
cells (D). E: Pre-absorption of the primary antibody with TNF-R1 peptide did not stain any cells in the tracheal epithelium. F: In addition experiments
omitting primary antibody were used as negative controls evoked no immunoreactive staining of epithelial structures. (Scale bars: 20 mm).
doi:10.1371/journal.pone.0091705.g004
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broad influence in many different inflammatory diseases [19] [20].
In a previous study it has been shown that TNF-a induces under
long term exposure a NO mediated increase in ciliary motility of
isolated and cultivated bovine airway epithelium cells [21]. In the
present study we observed that TNF-a already triggered during
short term exposure an elevation of both CBF and PTV. This
elevation of CBF and PTV of the whole intact tracheal epithelium
was independent from NO depending mechanisms that have been
described under long term exposure (see below).
Correspondent we observed a dose dependent effect of TNF-a
on ciliary bearing cells (figure 2B), that became obvious under
constant exposure to TNF-a within 60 minutes. A dose and time
related cell response to TNF-a application is heterogeneous, and
depends on the chosen cell lines, but seems to be a common effect
as it has been previously described. In the rhabdomyosarcoma cell
line KYM-1 exposure to TNF-a induces dose dependent apoptosis
via a pro-apoptotic caspase activation and in parallel it triggers the
nuclear factor kB (NF-kB)-mediated survival pathways [22].
Furthermore TNF-a-effects onto immune cells seem also dose
dependent, high doses evoked maximal adhesion of murine
progenitor T cells to murine arterial endothelial cells, to human
umbilical endothelial cells or to bovine aortic endothelial cells [23].
TNF-a may not only activate genuine immune cells, thus it also
activates cell types closely involved in inflammatory defence
mechanisms. The results of the present study not only provided
evidence for increased CBF. Moreover we measured increased
mechanical transport capacity in different experimental setups
strongly correlating to the change in CBF (see figure 3), which
corresponds to earlier findings of an elevation of CBF of isolated
bovine cells exposed to TNF-a after 24 hrs [21]. However, here we
used organ explant experiments to achieve in vivo related
conditions, in which interaction and effective TNF-a concentra-
tions may differ from isolated ciliary bearing cells. According to
the close location between TNF-a producing cells, like alveolar
macrophages or other pro-inflammatory cells, and their target
cells, we applied higher TNF-a concentrations to achieve nearly
realistic conditions. In bronchoalveolar fluid of human patients
with acute respiratory distress syndrome TNF-a concentrations
can reach ranges above 10 ng/ml [24], but even higher local
concentrations ranging from 0.6 to 2400 ng/ml have been found
between intact cell structures [25]. For that reason we analysed the
effects of TNF-a concentrations in the range from 0 to 1000 ng/
ml, which turned out to be approved TNF-a concentrations
similar to local cell constellations including TNF-a producing cells.
[25], [26].
Currently two TNF-a receptors are known that transpond the
effects to its target cells. The main target of TNF-a seems to be the
plasma membrane-bound receptor TNF-R1, which is expressed in
various cell types. However, the TNF-R2 is assumed to be located
only on immune cells, but may also alter organ function, via these
activated cells.
The mRNA of TNF-R1 was detected in whole trachea using
RT-PCR or qPCR. Immunohistochemical staining against TNF-
R1 protein revealed the location of this receptor being exclusively
located within the epithelium of the trachea under non-stimulated
control conditions (figure 4). In qPCR experiments we observed an
upregulation of TNF-R1 mRNA during exposure to TNF-a, albeit
it reached not statistical significance during the chosen exposure
period. Most probably the experimental setup of 60 min. exposure
time was too short to trigger a significant upregulation of the TNF-
R1 mRNA when using qPCR. Hence, we obtained no evidence
for the expression of TNF-R2 neither in control nor in TNF-a
treated tracheae (figure 4). Since, TNF-R1 mRNA was detected
when using whole trachea, we applied immunohistochemical
staining to localize the TNF-R1 protein. Our experiments clearly
provided evidence that the TNF-R1 protein is located within few
cells of the tracheal epithelium. This staining was proofed by an
adequate control for the specificity of the primary TNF-R1
antibody using pre-absorption with the TNF-R1 peptide and
omission of the primary antibody in a further series of experiment.
According to these present results, we assume that TNF-R1 is
exclusively expressed in the tracheal epithelium.
In experiments using TNF-R12/2 mice the response to TNF-a
was almost completely diminished, confirming a signal transduc-
tion pathway via TNF-R1. Additionally the concentration
dependent effect to TNF-a application (360 ng/ml; 1000 ng/ml)
was extinguished in TNF-R12/2 mice. Activation of TNF-R1
Figure 5. TNF-a effects are reduced in TNF-R12/2 mice. A: The
recording shows the highest concentration of TNF-a (1000 ng/ml)
applied. In wt-J mice it resulted in an increase of the CBF becoming
significant between minute 48 and minute 60 compared to TNF-R12/2
mice using Mann Whitney U-test (p,0.05, Mean 6 S.E.M.). B: The dose
dependency of TNF-a induced increase in CBF in wt-J mice became
significant between minute 60 and minute 120 (p,0.05). This
significant difference can not be provoked, when TNF-a is applied at
TNF-R12/2 tracheae (p.0.05, Mann Whitney U-test. Mean 6 S.E.M.,
n = 40 cells from 4 tracheae out of 4 animals).
doi:10.1371/journal.pone.0091705.g005
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seems to be the main pathway of TNF-a evoked responses in cilia
bearing cells which are non immunological cells. Further TNF-R1
plays not only in the tracheal epithelium a pivotal role for cell
activation but also in lower airway smooth muscle cells. Despite
the coexistence of both TNF-R2 and TNF-R1 in this cell line, the
latter plays the key role for activation of nuclear factor-kB
transcription factor function or calcium-signal potentiation and
contributes to overreaction of bronchial airway muscle during
inflammation [27] [28] [29]. These observations are in line with
our findings, indicating that TNF-R1 is the principle signal
converter for TNF-a induced activation of ciliary function.
Ciliary function is conducted continuously by physiological
neuromediators released from autonomic nerve fibres or from
adjacent cells in a paracrine pattern [8]. Alternative modulators
deriving from sources different from the above mentioned may
also contribute to the regulation of airway cell functions.
Stimulation of mice tracheal epithelial cells e. g. with serotonin
triggers a release of acetylcholine from epithelial cells resulting in a
subsequent contraction of the underlying smooth muscle cell layer
[7]. However on the one hand application of acetylcholine
increases rapidly CBF [30], on the other hand serotonin also
mediates an increase in CBF independent from the release of
acetylcholine [31]. Since both acetylcholine and serotonin seem to
generate independently an increase in ciliary activity we observed
the independent effects of both on cilia function. Among a
cholinergic stimulation of cGMP, which constitutes equal to
cAMP, an important messenger to activate a phosphorylation and
mediate an increase in cilliary beat frequency, NO induces the
synthesis of cGMP based on activation of soluble guanylyl cyclase
[32] [33] [34] [4]. But neither inhibition of NO generation in the
present study using L-NMMA or L-NAME did prevent the TNF-a
induced increase in PTV, nor a muscarinic receptor blockade
using atropine was able to reduce or inhibit the response to TNF-
a. Yet application of methysergide an unspecific serotonin
Figure 6. Inhibition of TNF-a induced PTV by serotonin receptor blockade. Mice tracheae were analysed at minute 60. A: Atropine (1 mM,
n= 4) or L-NMMA (100 mM, n= 4) did not prevent the increase in PTV as a response to TNF-a (360 ng/ml) application. B: The serotonin antagonist
methysergide (100 mM) reduced the TNF-a (360 ng/ml) evoked increase in PTV (p,0.05). In contrast 1 mM WAY-100635 (a specific 5-HT1A receptor
antagonist) did not reduce the TNF-a evoked increase in PTV (p = 0.22). Cyproheptadine (specific 5-HT2 receptor antagonist, 5 mg/ml) blocked the
TNF-a induced PTV elevation (p,0.01, n = 9 in control, n = 5 in all other experiments, Mann Whitney U-test. Mean 6 S.E.M.).
doi:10.1371/journal.pone.0091705.g006
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antagonist completely prevented the TNF-a induced increase in
CBF and PTV. In addition only cyproheptadine a selective 5-HT2
serotonin receptor antagonist but not WAY-100635 a selective 5-
HT1A serotonin receptor antagonist could inhibit the TNF-a
induced ciliary activation (figure 6). This strongly indicates that
serotonin may contribute in this activation cascade via its receptor
5-HT2.
Serotonin is a derivative from tryptophan and known as a
neurotransmitter released mainly from neuroendocrine cells. It is
as well a regulator for various biological processes even outside the
central nervous system. It has direct influence on the cardiovas-
cular system, e.g. regulation of the heart rate. Especially in the
gastrointestinal tract serotonin plays an important role, here it
stimulates intestinal peristalsis and intestinal secretion. In the lung
serotonin is involved in the pathogenesis of pulmonary hyperten-
sion, during hypoxia the intravascular serotonin concentration
increases which then results in a rise in 5-HT2B receptor signaling
of endothelial cells from pulmonary arteries consequently increas-
ing vascular resistance [35] [36] [37]. In addition serotonin as well
induces pulmonary artery remodeling by hypertrophy of smooth
muscle cells, this goes in parallel to the enhanced expression of the
serotonin transporter (SERT) [38] [39] [40]. This mechanism is
similar to the activation of platelet aggregation by SERT [41] [42].
Both link inflammatory processes with different cell functions that
are primarily not associated to the specific immune system, similar
to our observation. So far we assume that TNF-a induces the
increase of PTV and CBF by serotonin release, since we were able
to completely inhibit the response to TNF-a by pharmacological
inhibition of serotonin receptors in general and specifically by the
inhibition of 5-HT2. We further presume that serotonin is released
from granules probably deriving from mast cells that are located in
the trachea, thus this has to be clarified in further studies [31]. In
addition to the fact that mast cells release TNF-a under
inflammatory conditions, they themselves can be stimulated by
TNF-a via binding to TNF-R1 [43]. Likewise, serotonin derived
from mast cells in the mouse trachea are known to activate 5-HT2
receptors on parasympathetic cholinergic neurons, which lead to
acetylcholine release and airway smooth muscle contraction [44].
In our experiments the TNF-a induced increase in PTV and CBF
was completely inhibited by methysergide, an unspecific serotonin
receptor blocker and cyproheptadine a specific 5-HT2 serotonin
receptor blocker. Therefore we assume an early TNF-a induced
serotonin dependent action onto the ciliary activity, that is
independent from the late increase in CBF as has been reported
for isolated and cultivated bovine cilia bearing cells [21].
Furthermore in our experimental set up inhibition of NO or
acetylcholine dependent signaling pathways did not interact with
the observed TNF-a-stimulation. Thus, we assume that serotonin
derives from mast cells and triggers the increases in PTV and CBF
via the 5-HT2 serotonin receptor.
In conclusion we assume that TNF-a induces an increase in
PTV and CBF by binding to TNF-R1 on tracheal mast cells which
then release serotonin that stimulates the 5-HT2 serotonin
receptor on cilia bearing cells. This cascade may function as a
protective mechanism during early periods of inflammation or
developing pneumonia.
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